Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Long-term effectiveness of highly active antiretroviral therapy (HAART) in perinatally HIV-infected children in Denmark.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Molecular imaging in Libman-Sacks endocarditis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Mycobacterium bovis meningitis in young Nigerian-born male

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Undetectable hepatitis C virus RNA during syphilis infection in two HIV/HCV-co-infected patients

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Pneumocystis jirovecii pneumonia in patients with end-stage renal disease: a comparison with the general population

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Antibacterial use in the Faroe Islands, Iceland, and Denmark 1999-2011

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Hospital admission among HIV-exposed uninfected children compared to HIV-unexposed children - a nationwide cohort study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Clinical characteristics and laboratory findings in Danish children hospitalized with primary Epstein-Barr virus infection

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Salmonella er en sjælden årsag til meningitis hos nyfødte

    Publikation: Bidrag til tidsskriftTidsskriftartikelFormidling

  4. Clinical characteristics of children with Mycoplasma pneumoniae infection hospitalized during the Danish 2010-2012 epidemic

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer
The long-term impact of highly active antiretroviral therapy (HAART) on HIV-1 infected children is not well known. The Danish Paediatric HIV Cohort Study includes all patients <16 y of age with HIV-1 infection in Denmark. We report the complete follow-up from 1996 to 2005 of 49 perinatally infected children treated with HAART. Initial HAART included 2 nucleoside reverse-transcriptase inhibitors in combination with either a protease inhibitor (n =38) or a non-nucleoside reverse-transcriptase inhibitor (n =12). 19 (39%) patients were previously treated with mono- or dual therapy. Baseline characteristics were median CD4 percentage 14% and HIV-RNA viral load 4.9 log(10). Within the first 12 weeks of therapy approximately 60% achieved HIV-RNA viral load <500 copies/ml, and this remained stable for up to 8 y, although many children changed the components of HAART. The proportion of children with CD4 percentage >25% increased to 60-70% over the y of treatment. For the total cohort, 245 patient-y of observation were available with only 1 death. During our observation period there were no signs of a waning impact. The challenge remains to maintain a high adherence to therapy as the children grow into adolescence and develop more independence from family and health care staff.
Udgivelsesdato: 2007-null
OriginalsprogEngelsk
TidsskriftScandinavian Journal of Infectious Diseases
Vol/bind39
Udgave nummer9
Sider (fra-til)799-804
Antal sider5
ISSN0036-5548
DOI
StatusUdgivet - 2007

ID: 32543142